• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Freedom Acquisition I Corp. Cl A filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    12/13/24 9:07:36 AM ET
    $FACT
    Get the next $FACT alert in real time by email
    8-K 1 ea0224728-8k_fact2acq.htm CURRENT REPORT

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): December 13, 2024

     

    FACT II ACQUISITION CORP.

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   001-42421   N/A
    (State or other jurisdiction of
    incorporation or organization)
      (Commission File Number)   (I.R.S. Employer
    Identification Number)  

     

    14 Wall Street, 20th Floor
    New York, New York
    United States of America
      10005
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (212) 618-1798

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant   FACTU   Nasdaq Global Market
    Class A ordinary shares, par value $0.0001 per share, included as part of the units   FACT   Nasdaq Global Market
    Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   FACTW   Nasdaq Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 8.01. Other Events.

     

    On December 13, 2024, FACT II Acquisition Corp. (the “Company”) announced that the holders of the Company’s units sold in the Company’s initial public offering (the “Units”) may elect to separately trade the Class A ordinary shares, par value $0.0001 per share (the “Class A ordinary shares”), and redeemable warrants (the “warrants”) included in the Units commencing on December 20, 2024. Each Unit consists of one Class A ordinary share and one-half of one warrant to purchase one Class A ordinary share. Any Units not separated will continue to trade on the Nasdaq Global Market (“Nasdaq”) under the symbol “FACTU”. Any underlying Class A ordinary shares and warrants that are separated will trade on Nasdaq under the symbols “FACT” and “FACTW”, respectively. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. Holders of Units will need to have their brokers contact Odyssey Transfer and Trust Company, the Company’s transfer agent, in order to separate the holders’ Units into Class A ordinary shares and warrants.

     

    A copy of the press release issued by the Company announcing the separate trading of the securities underlying the Units is attached hereto as Exhibit 99.1.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    99.1  Press Release dated December 13, 2024

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: December 13, 2024

     

      FACT II ACQUISITION CORP.
       
      By: /s/ Adam Gishen
      Name:  Adam Gishen
      Title: Chief Executive Officer

     

     

    2

     

    Get the next $FACT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FACT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FACT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Freedom Acquisition I Corp. Cl A (Amendment)

      SC 13G/A - Complete Solaria, Inc. (0001838987) (Subject)

      2/14/24 4:05:45 PM ET
      $FACT
    • SEC Form SC 13G/A filed by Freedom Acquisition I Corp. Cl A (Amendment)

      SC 13G/A - Complete Solaria, Inc. (0001838987) (Subject)

      2/12/24 1:05:15 PM ET
      $FACT
    • SEC Form SC 13G filed by Freedom Acquisition I Corp. Cl A

      SC 13G - Complete Solaria, Inc. (0001838987) (Subject)

      9/22/23 4:22:56 PM ET
      $FACT

    $FACT
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by FACT II Acquisition Corp.

      SCHEDULE 13G - FACT II Acquisition Corp. (0002028935) (Subject)

      5/9/25 12:26:45 PM ET
      $FACT
    • SEC Form 10-K filed by FACT II Acquisition Corp.

      10-K - FACT II Acquisition Corp. (0002028935) (Filer)

      3/27/25 4:30:37 PM ET
      $FACT
    • SEC Form SCHEDULE 13G filed by FACT II Acquisition Corp.

      SCHEDULE 13G - FACT II Acquisition Corp. (0002028935) (Subject)

      3/7/25 1:57:19 PM ET
      $FACT

    $FACT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Complete Solaria, a Leading Solar Technology, Services, and Installation Company, Completes Business Combination with Freedom Acquisition I Corp. and Will Commence Trading on Nasdaq Under Ticker Symbol "CSLR"

      Complete Solaria is a differentiated solar company, with unique technology and end-to-end solar solutions, which includes financing, project fulfilment and customer service. Complete Solaria's digital platform together with premium solar products provide a one-stop service for customers. The transaction generated committed capital of more than $80 million in gross proceeds including capital from existing public shareholders of Freedom Acquisition I Corp., PIPE investors and investors pursuant to forward purchase agreements. The business combination will support Complete Solaria's goal to continue to scale to meet solar demand, further supporting the acceleration of the global energ

      7/17/23 6:21:00 PM ET
      $FACT
    • Boards of Complete Solaria and Freedom Acquisition I Corp. Approve Business Combination; Additional $10 Million Commitment Made by T.J. Rodgers

      The Boards of Directors of Complete Solaria, Inc. ("Complete Solaria" or the "Company") and Freedom Acquisition I Corp. ("Freedom") (NYSE:FACT), today announced approval of the proposed business combination. In addition, Complete Solaria and Freedom announced a $10 million commitment from T.J. Rodgers in connection with the proposed business combination. The proposed business combination would bring Complete Solaria to market, as a full system operator with a compelling end to end customer offering including best-in-class technology, financing, project fulfilment, and service. This transaction will help the company to continue to scale to meet demand, further supporting the acceleration o

      7/13/23 8:02:00 AM ET
      $FACT
    • Freedom Acquisition I Corp. Shareholders Approve Previously Announced Business Combination with Complete Solaria, Inc.

        Freedom Acquisition I Corp. ("Freedom") (NYSE:FACT), a publicly traded special purpose acquisition company, today announced that its shareholders voted to approve the previously announced business combination with Complete Solaria, Inc. ("Complete Solaria"), at the extraordinary general meeting of Freedom's shareholders held on July 11, 2023 (the "Special Meeting"). Votes representing over 76.9% of the issued and outstanding ordinary shares of Freedom were cast in favor of the approval of the proposal in connection with the business combination at the Special Meeting. Freedom shareholders also voted to approve all other proposals presented at the Special Meeting. Freedom plans to file

      7/12/23 7:30:00 AM ET
      $FACT

    $FACT
    Financials

    Live finance-specific insights

    See more
    • Complete Solaria, an Industry-Leading Solar Services, Financing and Products Company, to Publicly List on NYSE through Business Combination with Freedom Acquisition I Corp.

      Complete Solaria has entered into a definitive business combination agreement with Freedom Acquisition I Corp. (NYSE:FACT) ("Freedom"). Upon closing of the business combination, which is expected in the first half of 2023, the combined Company is expected to be listed on the New York Stock Exchange under the new ticker "CSLR". Complete Solaria brings together two highly complementary businesses in a vertically integrated manufacturing and distribution model, delivering end to end residential solar solutions, world-class customer service, aesthetically appealing, high-performance solar panels, as well as project financing, design and software solutions, to the U.S.A and beyond. Complete

      10/3/22 9:09:00 AM ET
      $FACT

    $FACT
    Leadership Updates

    Live Leadership Updates

    See more

    $FACT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Complete Solaria Appoints Industry Veteran Brian Wuebbels as Chief Financial Officer

      Complete Solaria, Inc. ("Complete Solaria" or the "Company"), a leading solar technology, services, and installation company, today announced that Brian Wuebbels has been named Chief Financial Officer, effective February 1, 2023. Wuebbels brings more than 20 years of financial and executive experience, having served as CFO and in senior leadership positions for public and private solar and industrial companies throughout his career, including companies such NIDEC, GCL Solar Materials, SunEdison, Honeywell, and General Electric. "I am pleased to welcome Brian to our leadership team," said Will Anderson, Complete Solaria CEO. "Brian's deep and extensive public and private company experience

      2/1/23 8:30:00 AM ET
      $FACT
    • Apexigen Announces Appointment of Francis Sarena as Chief Operating Officer

      SAN CARLOS, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced the appointment of Francis Sarena as Chief Operating Officer. Mr. Sarena will be responsible for leading strategic operations, driving business development, overseeing finance and investor relations and optimizing organizational functions. "We are thrilled to welcome Francis, an accomplished industry veteran, during this important phase of Apexigen's evolution," said Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer of Apexigen. "His deep biopharmaceut

      1/4/22 8:00:00 AM ET
      $FACT
      $FPRX
      $PDLI
      Major Pharmaceuticals
      Health Care
      Biotechnology: Biological Products (No Diagnostic Substances)
    • Amendment: New insider Fact Ii Acquisition Llc claimed ownership of 440,000 units of Class A ordinary shares (SEC Form 3)

      3/A - FACT II Acquisition Corp. (0002028935) (Issuer)

      2/14/25 4:58:08 PM ET
      $FACT
    • SEC Form 3 filed by new insider Fact Ii Acquisition Llc

      3 - FACT II Acquisition Corp. (0002028935) (Issuer)

      11/25/24 9:58:18 PM ET
      $FACT
    • SEC Form 3 filed by new insider Rackind Robert

      3 - FACT II Acquisition Corp. (0002028935) (Issuer)

      11/25/24 9:56:28 PM ET
      $FACT